UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Sells 15,813 Shares of HCA Healthcare, Inc. $HCA

Key Points

• UBS Asset Management reduced its stake in HCA Healthcare by 0.9%, selling 15,813 shares and leaving it with approximately 1.66 million shares valued at about $573 million.
• HCA Healthcare reported earnings of $6.84 per share for the last quarter, exceeding analysts' estimates, with a revenue of $18.61 billion that was 6.4% higher year-over-year.
• The company declared a quarterly dividend of $0.72 per share, with the ex-dividend date set for September 16, indicating a 0.7% yield based on the current stock price.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 0.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,659,647 shares of the company's stock after selling 15,813 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned 0.69% of HCA Healthcare worth $573,491,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. GAMMA Investing LLC raised its position in shares of HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock worth $5,887,850,000 after purchasing an additional 1,699,713 shares during the period. Nuveen LLC bought a new stake in HCA Healthcare during the 1st quarter worth $569,217,000. Pacer Advisors Inc. grew its position in shares of HCA Healthcare by 6,237.9% in the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock valued at $466,815,000 after buying an additional 1,329,618 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after buying an additional 1,091,416 shares during the period. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after acquiring an additional 587,036 shares during the period. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Down 1.1%

Shares of NYSE HCA opened at $413.63 on Wednesday. The stock has a 50 day moving average price of $381.31 and a 200 day moving average price of $361.47. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The firm has a market capitalization of $96.78 billion, a price-to-earnings ratio of 17.39, a PEG ratio of 1.31 and a beta of 1.41. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $420.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the prior year, the business earned $5.50 earnings per share. HCA Healthcare's revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

Insiders Place Their Bets

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 1.30% of the company's stock.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent research reports. Barclays reduced their price objective on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research report on Monday, July 28th. Wells Fargo & Company decreased their price objective on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a report on Thursday, August 14th. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Robert W. Baird increased their price objective on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a report on Thursday, August 14th. Finally, Morgan Stanley dropped their price objective on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a report on Monday, July 28th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $401.83.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.